X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1065) 1065
Publication (102) 102
Book / eBook (83) 83
Book Chapter (5) 5
Book Review (4) 4
Data Set (1) 1
Dissertation (1) 1
Magazine Article (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (653) 653
male (453) 453
female (450) 450
index medicus (433) 433
infectious diseases (400) 400
adult (394) 394
hiv infections - drug therapy (315) 315
middle aged (303) 303
hiv (288) 288
immunology (241) 241
viral load (179) 179
aids (178) 178
antiretroviral therapy (157) 157
virology (157) 157
hiv infection (155) 155
human immunodeficiency virus--hiv (153) 153
microbiology (152) 152
cd4 lymphocyte count (147) 147
treatment outcome (147) 147
hiv infections - virology (145) 145
aged (128) 128
anti-hiv agents - therapeutic use (128) 128
risk factors (124) 124
drug therapy (123) 123
hiv infections - immunology (114) 114
prospective studies (110) 110
mortality (109) 109
research (104) 104
antiretroviral therapy, highly active (102) 102
health aspects (102) 102
antiretroviral drugs (99) 99
infection (93) 93
hiv-1 (86) 86
pharmacology & pharmacy (86) 86
cohort studies (82) 82
therapy (81) 81
human-immunodeficiency-virus (80) 80
drug therapy, combination (79) 79
hiv infections - complications (79) 79
care and treatment (78) 78
highly active antiretroviral therapy (78) 78
hiv-1 - drug effects (78) 78
antiviral agents (77) 77
human immunodeficiency virus (77) 77
infections (76) 76
protease inhibitors (75) 75
medicine (74) 74
spain (74) 74
acquired immune deficiency syndrome--aids (72) 72
clinical trials (72) 72
aids/hiv (71) 71
diagnosis (71) 71
medicine, general & internal (70) 70
research article (70) 70
active antiretroviral therapy (68) 68
anti-hiv agents - administration & dosage (68) 68
analysis (67) 67
hiv patients (66) 66
anti-hiv agents - adverse effects (64) 64
vih (62) 62
antiretrovirals (61) 61
antiretroviral agents (60) 60
disease progression (59) 59
hiv-1 - genetics (59) 59
patients (59) 59
efficacy (58) 58
young adult (58) 58
epidemiology (57) 57
adolescent (56) 56
hiv-1-infected patients (55) 55
rna, viral - blood (55) 55
spain - epidemiology (55) 55
science (54) 54
hiv infections (52) 52
prognosis (52) 52
viruses (51) 51
hiv infections - epidemiology (50) 50
hiv-1 - isolation & purification (50) 50
multidisciplinary sciences (49) 49
cd4 antigen (48) 48
follow-up studies (48) 48
retrospective studies (48) 48
acquired immune deficiency syndrome (46) 46
infectious disease (46) 46
prevalence (46) 46
efavirenz (45) 45
hiv-infected patients (45) 45
rna (45) 45
drug resistance (44) 44
hiv protease inhibitors - therapeutic use (44) 44
hiv-1 - physiology (44) 44
time factors (43) 43
adults (42) 42
hiv infections - mortality (42) 42
infective endocarditis (42) 42
patient outcomes (42) 42
risk-factors (42) 42
reverse transcriptase inhibitors - therapeutic use (41) 41
t cells (41) 41
antiretroviral therapy, highly active - methods (40) 40
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
UTL at Downsview - May be requested (47) 47
Robarts - Stacks (28) 28
Pontifical Inst. Mediaeval Studies - Library use only (6) 6
Robarts - Storage (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Gerstein Science - Stacks (3) 3
Pontifical Inst. Mediaeval Studies - Reference (2) 2
St. Michael's College (John M. Kelly) - 3rd Floor (2) 2
Architecture Landscape (Shore + Moffat) - Stacks (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Robarts - May be requested in 6-10 wks (1) 1
Scarborough Hospital - Birchmount (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (935) 935
Spanish (206) 206
Portuguese (33) 33
Catalan (5) 5
Latin (4) 4
Italian (2) 2
German (1) 1
Japanese (1) 1
Romance (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA, ISSN 0098-7484, 08/2008, Volume 300, Issue 5, pp. 555 - 570
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2019, Volume 14, Issue 5, p. e0216712
Journal Article
Journal Article
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2015, Volume 15, Issue 7, pp. 785 - 792
Journal Article
The Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 03/2010, Volume 65, Issue 3, p. 383
The question about when to start antiretroviral therapy in HIV-1-infected patients has been debated since the discovery of the first antiretroviral agent... 
Antiretroviral drugs | Lymphocytes | Human immunodeficiency virus--HIV | Pharmacology | T cell receptors | Drug therapy
Journal Article
Lancet, The, ISSN 0140-6736, 2007, Volume 369, Issue 9569, pp. 1261 - 1269
Summary Background Raltegravir (MK-0518) is an HIV-1 integrase inhibitor with potent in-vitro activity against HIV-1 strains including those resistant to... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | ANTIRETROVIRAL DRUGS | THERAPY | HIV-1-INFECTED INDIVIDUALS | INFECTION | DRUG-RESISTANCE | PREVALENCE | ENFUVIRTIDE | HIV-1 | Drug Resistance, Multiple | Humans | Middle Aged | Male | HIV Integrase Inhibitors - administration & dosage | Viral Load | Oligopeptides - therapeutic use | Dose-Response Relationship, Drug | Atazanavir Sulfate | Adult | Female | Raltegravir Potassium | Organic Chemicals - administration & dosage | Pyridines - therapeutic use | Double-Blind Method | Organic Chemicals - adverse effects | Organic Chemicals - therapeutic use | Logistic Models | Treatment Outcome | Pyrrolidinones | HIV Integrase Inhibitors - adverse effects | Adolescent | HIV Integrase Inhibitors - therapeutic use | HIV Infections - drug therapy | Aged | Pyridines - pharmacology | Oligopeptides - pharmacology | Viral drug resistance | Care and treatment | Dosage and administration | Drug therapy | HIV infection | Raltegravir | Design | Studies | Antiretroviral drugs | Plasma | Inhibitor drugs | Protease inhibitors | Conferences | Human immunodeficiency virus--HIV | Mortality | Gene expression | Drug resistance | Patients | RNA-directed DNA polymerase | Laboratories | Toxicity | Viruses | Genomes | Randomization | Motivation | Antiretroviral agents | Nucleoside reverse transcriptase inhibitors | Safety | Drug dosages | Integrase | Phenotypes | Effectiveness | Proteinase inhibitors | Ribonucleic acid--RNA | Antiretroviral therapy | CD4 antigen | Non-nucleoside reverse transcriptase inhibitors | Inhibitors | Nucleosides | Index Medicus | Abridged Index Medicus
Journal Article